Lentiviral gene therapy could offer relief to refractory epilepsy patients

An epilepsy gene therapy from UCL could offer an alternative to brain surgery

Within a year, University College London researchers hope to begin a clinical trial of a gene therapy for epilepsy, a non-monogenic disorder. The hope is that the approach will offer an alternative to brain surgery for patients who fail to respond to oral therapies.

In

Read the full 444 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE